Ovalbumin Powder Market

The ovalbumin powder market is The global ovalbumin powder market has been segmented on the basis of product types, such as standard ovalbumin powder, modified ovalbumin powder, and ovalbumin hydrolysate. The modified ovalbumin powder segment is expected to witness the highest growth during the forecast period owing to its novel properties, such as anti-inflammatory, immunomodulatory, and wound healing benefits. On the basis of end users, the market is segmented into pharmaceuticals, food and beverage, agriculture and allied sectors, health care and diagnostics, and other industries. Pharmaceuticals are expected to account for a majority share in the global ovalbumin powder market due to their diversified applications in various healthcare segments.

Ovalbumin powder is a tasteless, white powder that comes from the secretions of egg cells. It is used as a food additive and as a filler in foods. The major factors driving this market are rising awareness about allergies and asthma, the increasing number of people suffering from chronic respiratory illnesses, and continuous research and development in the field of allergy diagnostics.

The ovalbumin powder market is estimated to be worth $** billion in 2031 and is expected to grow at a CAGR of **% during the forecast period of 2018–2031.

Some of the prominent vendors in the global ovalbumin powder market include Bioseutica, Sisco Research Laboratories Pvt. Ltd., Dalian Hanovo Foods Co., Ltd., Thermo Fisher Scientific, Neova Technologies Inc., Merck & Co. Inc., Modernist Pantry, LLC, Huzhou Zhenlu Biological Products Co., Ltd., Research Products International Corporation, and Kewpie Corporation.